Literature DB >> 2180567

Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.

S H Bigner1, H S Friedman, B Vogelstein, W J Oakes, D D Bigner.   

Abstract

Cultured cell lines and xenografts derived from 7 human medulloblastomas were evaluated for amplification of the c-myc, N-myc, epidermal growth factor receptor, and gli genes by Southern blot analysis. Karyotypes of the original biopsies and early passaged cells demonstrated double minute chromosomes in 4 of the 7 cases. All 7 samples (3 cell lines and 4 xenografts) from the 4 tumors with double minute chromosomes contained amplification of the c-myc gene. Cell lines and xenografts derived from the 3 biopsies without double minute chromosomes failed to demonstrate amplification of the 4 genes which were tested, but a rearrangement of the c-myc gene occurred in 1 of the 3 tumors. These observations demonstrate that the c-myc gene is often amplified and/or rearranged in human medulloblastomas and suggest that amplification of this gene provides a growth advantage for medulloblastoma cells in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180567

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  60 in total

1.  Fabrication and testing of a device capable of reducing the incidence of ventricular shunt promoted metastasis.

Authors:  E C Halperin; T Samulski; W J Oakes; H S Friedman
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences.

Authors:  Leonora Balaj; Ryan Lessard; Lixin Dai; Yoon-Jae Cho; Scott L Pomeroy; Xandra O Breakefield; Johan Skog
Journal:  Nat Commun       Date:  2011-02-01       Impact factor: 14.919

3.  Nerve growth factor receptor expression in peripheral and central neuroectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland.

Authors:  D L Baker; W M Molenaar; J Q Trojanowski; A E Evans; A H Ross; L B Rorke; R J Packer; V M Lee; D Pleasure
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

Review 4.  The radiation treatment of medulloblastoma.

Authors:  D Jenkin
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

Review 5.  Medulloblastoma: a historical perspective and overview.

Authors:  J T Rutka; H J Hoffman
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

6.  Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs.

Authors:  T D Levine; F Gao; P H King; L G Andrews; J D Keene
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

7.  Medulloblastoma in pediatric age: a single-institution review of prognostic factors.

Authors:  L Cervoni; G Cantore
Journal:  Childs Nerv Syst       Date:  1995-02       Impact factor: 1.475

8.  Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts.

Authors:  H S Friedman; P J Houghton; S C Schold; S Keir; D D Bigner
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 9.  Genetic alterations in glioma and medulloblastoma.

Authors:  B K Rasheed; S H Bigner
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

10.  The Human Glioma-Associated Oncogene Homolog 1 (GLI1) Family of Transcription Factors in Gene Regulation and Diseases.

Authors:  Hu Zhu; Hui-Wen Lo
Journal:  Curr Genomics       Date:  2010-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.